Article History
Accepted: 12 January 2020
First Online: 29 January 2020
Compliance with ethical standards
:
: The Department of Intensive Care Medicine (PZ, JCS) has/ had research & development/ consulting contracts with (full disclosure): Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH/ SA, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, and Nestlé. Educational grants have been received from Fresenius Kabi; GSK; MSD; Lilly; Baxter; Astellas; AstraZeneca; B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Roba Pharma), Phagenesis, Pfizer, Orion Pharma. No personal financial gain resulted from respective development/ consulting contracts and/or grants. JCS is principle investigator of the PHINEST study. The University Hospital Münster received case money in the PHAST TRAC-trial and the “Pharyngeal electrical stimulation for treatment of neurogenic dysphagia: a European Registry (PHADER)” study. RD has received travel expenses in his role as principal investigator in PHAST-TRAC and PHADER from Phagenesis Ltd. RD also received honoraria for serving as a consultant for Nestlé Health Science and worked as non-paid adviser for the company Phagenesis Ltd.